Camardo Daniel A.
Insider CIK 1820365 · ATHX Chief Executive Officer, Director · HZNP EVP and President, U.S. · CUE Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CUE Cue Biopharma, Inc. | A Award | 2026-07-09 | 2026-07-10 | 21,800 | — | $0 | 21,800 | SEC↗ |
| CUE Cue Biopharma, Inc. | A Award deriv | 2026-05-30 | 2026-06-08 | 1,626 | — | $0 | 1,626 | SEC↗ |
| ATHX ATHERSYS, INC / NEW | F Tax w/h | 2023-10-04 | 2023-10-06 | 19,993 | $0.44 | $8.8K | 285,341 | SEC↗ |
| ATHX ATHERSYS, INC / NEW | F Tax w/h | 2023-07-05 | 2023-07-06 | 19,993 | $0.91 | $18.2K | 305,334 | SEC↗ |
| ATHX ATHERSYS, INC / NEW | F Tax w/h | 2023-04-04 | 2023-04-05 | 19,993 | $1.00 | $20.0K | 325,327 | SEC↗ |
| ATHX ATHERSYS, INC / NEW | F Tax w/h | 2023-01-04 | 2023-01-06 | 23,484 | $0.85 | $20.0K | 345,320 | SEC↗ |
| ATHX ATHERSYS, INC / NEW | P Buy | 2022-11-22 | 2022-11-22 | 100,000 | $0.55 | $55.0K | 368,804 | SEC↗ |
| ATHX ATHERSYS, INC / NEW | A Award | 2022-10-04 | 2022-10-06 | 263,492 | — | $0 | 268,804 | SEC↗ |
| ATHX ATHERSYS, INC / NEW | P Buy | 2022-03-17 | 2022-03-17 | 132,800 | $0.77 | $102.3K | 132,800 | SEC↗ |
| ATHX ATHERSYS, INC / NEW | A Award deriv | 2022-02-14 | 2022-02-14 | 4,000,000 | — | $0 | 4,000,000 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2021-04-05 | 2021-04-05 | 2,305 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2021-04-05 | 2021-04-05 | 15,467 | — | $0 | 4,333 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2021-04-05 | 2021-04-05 | 509 | — | $0 | 3,441 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2021-04-05 | 2021-04-05 | 2,305 | $17.19 | $39.6K | 35,205 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2021-04-05 | 2021-04-05 | 509 | $15.23 | $7.8K | 51,181 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2021-04-05 | 2021-04-05 | 15,467 | $25.52 | $394.7K | 50,672 | SEC↗ |
| HZNP Horizon Therapeutics Publi | S Sale | 2021-03-30 | 2021-03-31 | 3,517 | $86.87 | $305.5K | 32,900 | SEC↗ |
| HZNP Horizon Therapeutics Publi | S Sale | 2021-03-30 | 2021-03-31 | 1,803 | $83.58 | $150.7K | 43,997 | SEC↗ |
| HZNP Horizon Therapeutics Publi | S Sale | 2021-03-30 | 2021-03-31 | 4,594 | $84.97 | $390.4K | 39,403 | SEC↗ |
| HZNP Horizon Therapeutics Publi | S Sale | 2021-03-30 | 2021-03-31 | 2,986 | $85.88 | $256.4K | 36,417 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2021-02-21 | 2021-02-23 | 1,300 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | F Tax w/h | 2021-02-21 | 2021-02-23 | 576 | $88.87 | $51.2K | 45,800 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2021-02-21 | 2021-02-23 | 1,300 | — | $0 | 46,376 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2021-01-21 | 2021-01-22 | 3,220 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2021-01-21 | 2021-01-22 | 3,220 | — | $0 | 46,503 | SEC↗ |
| HZNP Horizon Therapeutics Publi | F Tax w/h | 2021-01-21 | 2021-01-22 | 1,427 | $77.43 | $110.5K | 45,076 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2021-01-05 | 2021-01-06 | 5,634 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2021-01-05 | 2021-01-06 | 4,354 | — | $0 | 8,708 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2021-01-05 | 2021-01-06 | 10,626 | — | $0 | 10,626 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2021-01-05 | 2021-01-06 | 20,614 | — | $0 | 52,513 | SEC↗ |
| HZNP Horizon Therapeutics Publi | F Tax w/h | 2021-01-05 | 2021-01-06 | 9,230 | $73.28 | $676.4K | 43,283 | SEC↗ |
| HZNP Horizon Therapeutics Publi | A Award deriv | 2021-01-04 | 2021-01-06 | 20,957 | — | $0 | 20,957 | SEC↗ |
| HZNP Horizon Therapeutics Publi | S Sale | 2020-11-06 | 2020-11-06 | 3,500 | $76.76 | $268.7K | 30,829 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2020-10-01 | 2020-10-22 | 10,000 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | A Award | 2020-10-01 | 2020-10-22 | 10,000 | — | $0 | 38,789 | SEC↗ |
| HZNP Horizon Therapeutics Publi | F Tax w/h | 2020-10-01 | 2020-10-22 | 4,460 | $80.42 | $358.7K | 34,329 | SEC↗ |
| HZNP Horizon Therapeutics Publi | A Award deriv | 2020-08-03 | 2020-08-05 | 17,102 | — | $0 | 17,102 | SEC↗ |